Drug intelligence / Profile preview

epigallocatechin gallate + folic acid + vitamin B12 + hyaluronic acid

Development stage
Phase 2
Lead developer
Lo.Li. Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Pervistop is an oral dietary supplement combination containing epigallocatechin gallate (EGCG), folic acid, vitamin B12, and hyaluronic acid, developed by Lo.Li. Pharma. It is specifically formulated to support the clearance of Human Papillomavirus (HPV) and manage HPV-related cervical cytological abnormalities such as LSIL (Low-grade Squamous Intraepithelial Lesion) and ASCUS (Atypical Squamous Cells of Undetermined Significance). The primary active component, EGCG, acts by interfering with the HPV life cycle and suppressing the expression of the viral oncoproteins E6 and E7. This suppression leads to the stabilization and upregulation of the p53 tumor suppressor protein, which induces apoptosis in HPV-infected cells and counteracts viral persistence. Folic acid and vitamin B12 are included to support DNA synthesis and cellular health, while hyaluronic acid contributes to tissue integrity and repair.

Brand names
Pervistop
Other names
EGCG + FA + B12 + HA
02

Targets

B12-TCE (Vitamin B12 transport proteins and cofactor-dependent enzymes)

Beyond the preview

Go deeper on epigallocatechin gallate + folic acid + vitamin B12 + hyaluronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on epigallocatechin gallate + folic acid + vitamin B12 + hyaluronic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call